15 August. The MEDiscuss CDSS is soft-launching today, built for the units, the drugs and the guidance we actually use in Indian wards.
Adult Immunisation Advisor
Based on API Consensus Guidelines (2026), WHO & ACIP Recommendations · v1.8
How to use this tool: Enter the age, comorbidities and vaccination history. The tool returns the adult vaccines due, with doses and intervals, following Indian adult immunisation guidance.
1. Age Group
2. Biological Sex
3. Pregnant or Planning Pregnancy? ?
4. Comorbidities & Risk Factors ?
Patient Profile
-
Low Risk
Vaccines Indicated
0
Standard
Recommended Vaccines for This Patient
Contraindicated or Deferred
Clinical Rationale & Execution Notes
Evidence-Based Pearls & Pathophysiology
1. Practice Advisory: The Tetanus Toxoid (TT) Caution
Avoid Standalone TT: In India, there is a widespread unsafe practice of prescribing standalone Tetanus Toxoid (TT) for wound management or during pregnancy. Pathophysiology/Epidemiology: Due to waning adult immunity against Diphtheria (which relies on herd immunity), the Government of India officially replaced TT with Td (Tetanus & adult-dose Diphtheria) in the National Immunisation Schedule in 2019. You MUST prescribe Td or Tdap, never standalone TT.
2. Illness Script: Identifying Live Vaccines (Mnemonic)
Live attenuated vaccines carry a risk of uncontrolled viral or bacterial replication. They are strictly contraindicated in pregnant women (due to teratogenicity as pathogens cross the placenta) and severely immunocompromised patients.
Mnemonic: "Be A VIP, MMR!" BCG Adenovirus (oral) Varicella Influenza (LAIV - Intranasal only) Polio (OPV - Oral) Measles, Mumps, Rubella (MMR) *Also includes Yellow Fever and Zoster (ZVL/Zostavax).
3. Why Adult Immunisation Matters in India
Immunosenescence: Age-related decline in innate and adaptive immune function increases susceptibility and mortality to influenza, pneumococcal disease, and herpes zoster in older adults.
Comorbidity Burden: India's rising prevalence of diabetes, CKD, and COPD creates massive cohorts of patients whose baseline mucosal immunity is impaired, requiring targeted vaccination.
Avoid Simultaneous Administration Advisory: Never give PCV and PPSV23 at the same time. Simultaneous administration induces B-cell immune tolerance and blunts the antibody response.
API 2026 Shift: PCV20 is now the preferred single-dose pneumococcal vaccine. It covers 7 additional serotypes compared to PCV13, eliminating the need for the older, sequential PCV13 → (wait 1 year) → PPSV23 approach, which suffered from high drop-out rates and polysaccharide-induced hyporesponsiveness.
5. Herpes Zoster (Shingles) Vaccination
Vaccine Type
Pathophysiology & Recommendation
RZV (Shingrix) Recommended
Recombinant glycoprotein E antigen with AS01B adjuvant. Non-live. Highly immunogenic. Safe in immunocompromised patients. Recommended for ALL adults ≥50 years, and immunocompromised ≥18 years.
ZVL (Zostavax) Obsolete
Live-attenuated virus. Contraindicated in immunosuppression. Waning efficacy. No longer recommended by API or CDC.
6. Vaccination in Pregnancy
The goal is dual protection: protecting the mother from severe disease (e.g., Influenza) and providing passive transplacental IgG antibodies to the neonate (e.g., Pertussis).
Status
Vaccines
STRONGLY RECOMMENDED
Tdap: 27-36 weeks, in EACH pregnancy to maximise transplacental pertussis antibodies. Inactivated Influenza: Any trimester.
USE IF INDICATED
Hepatitis B (if at risk and unvaccinated); Pneumococcal.
CONTRAINDICATED
Live Vaccines (MMR, Varicella, LAIV, BCG, Yellow Fever). Wait at least 4 weeks after a live vaccine before conceiving. HPV is also deferred.
Association of Physicians of India (API). Indian Consensus Guidelines on Adult Immunization, 2026 Update. API; 2026.
Dhawan AM, Desai A, Gvalani A, Anand S, Das P. A comprehensive review of the latest Indian guidelines on adult immunization. Int J Community Med Public Health. 2025;12(2):1159-1165.
Centers for Disease Control and Prevention (CDC). Adult Immunization Schedule by Age. ACIP; Updated 2026.
Giriappa B, Choraria N, Ponce P, et al. Immunogenicity and safety of 20-valent PCV (PCV20) in adults ≥18 y of age in India. Hum Vaccin Immunother. 2026;22(1):2605847.
World Health Organization. WHO Recommendations for Routine Immunization: Summary Tables. Geneva: WHO; 2023.
How to Cite This Tool
AMA Style:
Umakanth S. Adult Immunisation Advisor. MEDiscuss. Published 2026. Accessed .
Vancouver Style:
Umakanth S. Adult Immunisation Advisor [Internet]. MEDiscuss.org; 2026 [cited ]. Available from:
Save this calculation
Whatever you type here stays on this device and is not sent anywhere. The server
receives only a scrambled code made from it, so nobody with access to the server can
tell which patient a saved calculation belongs to. Enter the same nickname the next
time to see that patient's earlier values.
What is stored